These three LNG plays are worthy investments, Jim Cramer says

These three LNG plays are worthy investments, Jim Cramer says


CNBC’s Jim Cramer on Tuesday picked three liquified natural gas stocks investors should consider purchasing.

“Two are pure plays on liquefied natural gas exports – a little dicier – and then one is a more diversified story, really perfect for home-gamers who are worried about volatility,” the “Mad Money” host said.

Russia’s ongoing invasion of Ukraine has led the U.S. to raise concerns about restricted supply of commodities, like energy and food, as well as implement economic sanctions against Russia. The U.S said in late March that it will work with global partners to provide upwards of 15 billion cubic meters of liquified natural gas to Europe this year in an attempt to lessen reliance on Russian imports. 

Natural gas futures for May rose 6.55% on Tuesday to about $6.10.

Here is Cramer’s list of three LNG stocks he believes instestors should be eyeing, starting with his favorite:

Sempra Energy

Sempra Energy is “not a pure play, but does have a nice LNG export business,” Cramer said.

“I like it long-term, as it’s the single best growth utility around with a terrific liquefied natural gas kicker. … If you’re looking for ways to play Europe’s demand for liquefied natural gas, I like Sempra Energy the best” he said, adding that the business is “consistent” and its stock is still cheap relative to the company’s earnings.

Cramer also discussed two other LNG stocks that he thinks could be investable: Cheniere Energy and Tellurian.

Cheniere Energy

“It’s the safest pure play in the industry. … Analysts expect Cheniere’s sales and earnings to peak this year. If you believe the LNG business can stay strong beyond 2022, then you’ve got my blessing to buy this one, but otherwise it’s possible the good news is already baked in and we are in, suddenly, a not great stock market,” Cramer said.

Tellurian

“Given that the stock has basically doubled since the end of last year, I think that you can afford to be patient here. Just wait for a better entry point,” Cramer said. 

Sign up now for the CNBC Investing Club to follow Jim Cramer’s every move in the market.

Disclaimer

Questions for Cramer?
Call Cramer: 1-800-743-CNBC

Want to take a deep dive into Cramer’s world? Hit him up!
Mad Money TwitterJim Cramer Twitter – Facebook – Instagram

Questions, comments, suggestions for the “Mad Money” website? [email protected]





Source

‘F1’ is Apple’s highest-grossing theatrical film ever
Business

‘F1’ is Apple’s highest-grossing theatrical film ever

Still from Apple’s “F1.” Apple Lights out and away we go. “F1: The Movie” hasn’t even reached the checkered flag of its theatrical run, but it’s already Apple’s best film release ever. The film, distributed by Warner Bros. Discovery, zoomed past $293 million at the global box office over the weekend. This outpaced Ridley Scott’s […]

Read More
Family offices ramp up deal-making in June with bets on biotech
Business

Family offices ramp up deal-making in June with bets on biotech

Key Points After a slow spring, investment firms of the ultra-rich made 60 direct investments in June, according to Fintrx. Family offices flocked to biotech and health-care firms such as Antheia, seeking to make an impact and returns at the same time. Antheia founder Christina Smolke told CNBC’s Inside Wealth family offices’ patient capital makes […]

Read More
How Netflix keeps luring big-name directors away from the traditional box office
Business

How Netflix keeps luring big-name directors away from the traditional box office

Film directors Rian Johnson (L), Greta Gerwig (C), and Guillermo Del Toro (R) Getty Images Netflix isn’t interested in bringing movies to theaters. The company’s leaders have said they see theatrical movie releases as an “outdated” model. Yet for more than a decade, the streamer has lured in some of Hollywood’s biggest directors to make content […]

Read More